Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 3/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25146224 | 0.85 | CA2 (0.34) | ADORA2AADORA1CA2 | |
| SCHEMBL31441242 | 0.78 | ADORA2A (0.31) | ADORA2AADORA1CA2 | |
| SCHEMBL31441244 | 0.78 | NEK1 (0.32) | ADORA2AADORA1CA2 | |
| SCHEMBL6127813 | 0.78 | CYP1A2 (0.39) | CYP1A2ALDH1A1 | |
| SCHEMBL20126955 | 0.77 | ALDH1A1 (0.32) | ADORA2AADORA1CA2ALDH1A1POLB | |
| SCHEMBL20126953 | 0.73 | ALDH1A1 (0.32) | ADORA2AADORA1CA2ALDH1A1POLB | |
| SCHEMBL17208936 | 0.71 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL21625566 | 0.71 | CYP1A2 (0.33) | CYP1A2ALDH1A1 | |
| SCHEMBL24819185 | 0.71 | DYRK1A (0.36) | CYP1A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL4802963 | 0.71 | KMT2A (0.38) | CYP1A2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3789379-A1 | 4-PHENYLBENZO[G]QUINAZOLINE OR 4-(3,5-DIMETHYLPHENYLBENZO[G]QUINAZOLINE IRIDIUM COMPLEXES FOR USE AS NEAR-INFRARED OR INFRARED EMITTING MATERIALS IN OLEDS | Universal Display Corporation (US) | 2021-03-10 | — | — | EP | disclosed |
| EP-3321258-B1 | 4-PHENYLBENZO[G]QUINAZOLINE OR 4-(3,5-DIMETHYLPHENYLBENZO[G]QUINAZOLINE IRIDIUM COMPLEXES FOR USE AS NEAR-INFRARED OR INFRARED EMITTING MATERIALS IN OLEDS | UNIVERSAL DISPLAY CORP (US) | 2020-12-23 | — | — | EP | disclosed |
| EP-3321258-A1 | 4-PHENYLBENZO[G]QUINAZOLINE OR 4-(3,5-DIMETHYLPHENYLBENZO[G]QUINAZOLINE IRIDIUM COMPLEXES FOR USE AS NEAR-INFRARED OR INFRARED EMITTING MATERIALS IN OLEDS | Universal Display Corporation (US) | 2018-05-16 | — | — | EP | disclosed |